These names frequently trade at low multiples to current assets and may (but may not) be worthy of purchase.
Just five non-biotech names trade below net current asset value.
With the S&P 500 at or near record highs, wait for prices to fall.
Searching for value plays produces few options, right now.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.